PeptiVir, Inc., a biopharmaceutical company, engages in the development and commercialization of synthetic peptide-based vaccines for the prevention of viral diseases. Its products include PVI-1000, an influenza vaccine for protection against various seasonal and pandemic strains. PeptiVir, Inc. was incorporated in 2010 and is based in Aurora, Colorado.

from http://site.peptivir.com/

Patents 2show all

  • 2
    C07K - Peptides

SEC Filings show all


1
D

Contact Information

12635 East Montview Blvd Suite 127
Aurora, CO 80045
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$300,0001-102010-11-18Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2010-11-18$300,000Seed

Key Executives

  • Robert S. Hodges
    Executive Officer, Director
  • Richard C. Duke
    Director
  • Kathryn V. Holmes
    Executive Officer, Director
  • Kevin Smith
    Executive Officer, Director